Investor Presentaiton

LANDAUERⓇ Compelling Investment Opportunity Global Leader in Occupational Radiation Products and Services Increased Regulation Drives Demand Compelling Growth and Expansion Opportunities Industry-leading technology; proprietary Optically Stimulated Luminescence (OSL) crystal manufacturing process Installed based of over 73,000 customers; 1.8 million individuals served 90% recurring revenue; 94% annual customer retention Ability to provide enterprise radiation management or product only model The Joint Commission standards effective in July 2015 in the United States Impacts 7,100 of the 20,500 U.S. healthcare organizations and programs, including hospitals, imaging clinics and certain ambulatory care centers - Estimated incremental cost of ~$30,000 annually for a hospital to comply with new standards International standards becoming more restrictive Next generation VerifiiTM product has commenced initial field testing Well positioned to meet emerging need for broader solution Differentiated position creates higher barrier to entry for competition Strong Financial Profile Strong margins and limited capital requirements deliver compelling free cash flow Defined capital allocation plan supports investment in growth initiatives and dividend Industry leading position, compelling market trends and strong financial profile drives long-term shareholder value

View entire presentation